Beijing, China

Nanmeng Song

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Beijing, CN (2021 - 2023)
  • Shunyi District, CN (2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: **Innovator Spotlight: Nanmeng Song – A Pioneer in Bispecific Antibody Development**

Introduction

Nanmeng Song is a distinguished inventor based in Beijing, China, known for his significant contributions to the field of biomedicine. With a remarkable portfolio of 8 patents, Song has made substantial advancements in the development of bispecific antibodies, targeting complex diseases through innovative therapeutic strategies.

Latest Patents

Among his latest patents are two groundbreaking bispecific antibodies:

1. **Anti-PD-1/anti-VEGF Natural Antibody Structure-like Heterodimeric Form Bispecific Antibody and Preparation Thereof** - This invention details a highly stable, heterodimeric bispecific antibody featuring natural IgG characteristics. It is designed without mismatched heavy and light chains, capable of binding to both PD-1 and VEGF target molecules simultaneously, thus enhancing the efficacy of treatment for complex diseases.

2. **Anti-PD-1/anti-HER2 Natural Antibody Structural Heterodimeric Bispecific Antibody and Method of Preparing Same** - This patent outlines a method for producing a stable heterodimeric bispecific antibody targeting both PD-1 and HER2. Similar to his previous invention, it boasts natural IgG characteristics and addresses the issue of chain mismatch, significantly improving its therapeutic potential.

Career Highlights

Nanmeng Song has an impressive background in the pharmaceutical industry. He has contributed his expertise while working at reputable companies, including Beijing Hanmi Pharmaceutical Co., Ltd. and Beijing Hanmi Pharm. Co., Ltd. His innovative approaches to antibody development have established him as a key figure in the realm of therapeutic research and development.

Collaborations

Throughout his career, Song has collaborated with various professionals, including notable coworkers Yaping Yang and Jiawang Liu. These partnerships have enabled him to expand his research capabilities and foster the development of cutting-edge biopharmaceuticals.

Conclusion

Nanmeng Song is a pioneering inventor whose work in bispecific antibody research is transforming the landscape of therapeutic interventions for complex diseases. With a strong track record of patents and collaborations, he continues to push the boundaries of innovation in biomedicine. As the field progresses, Song's contributions will undoubtedly play a crucial role in developing the next generation of targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…